-
G.
Leenders,
W.
Gage,
J.
Hicks,
Bianca
Balken,
T.
Aalders,
J.
Schalken,
A.
Marzo
(2003)
Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy.
The American journal of pathology, 162 5
-
S.
Dhanasekaran,
T.
Barrette,
D.
Ghosh,
R.
Shah,
S.
Varambally,
K.
Kurachi,
K.
Pienta,
M.
Rubin,
A.
Chinnaiyan
(2001)
Delineation of prognostic biomarkers in prostate cancer
Nature, 412
-
Yutong
Xue,
J.
Wong,
G.
Moreno,
Mary
Young,
J.
Côté,
Weidong
Wang
(1998)
NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.
Molecular cell, 2 6
-
Y.
Toh,
E.
Oki,
S.
Oda,
E.
Tokunaga,
S.
Ohno,
Y.
Maehara,
G.
Nicolson,
K.
Sugimachi
(1997)
Overexpression of the MTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasis
International Journal of Cancer, 74
-
M.
Rubin,
M.
Putzi,
N.
Mucci,
David
Smith,
K.
Wojno,
S.
Korenchuk,
K.
Pienta
(2000)
Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 6 3
-
Demarzo
Phd,
J.
Epstein,
Urology,
A.
DeMarzo,
W.
Nelson,
W.
Isaacs,
G.
Nelson,
Medicine,
J.
Epstein,
A.
DeMarzo,
W.
Nelson,
W.
Isaacs
For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii
-
H.
Sasaki,
S.
Moriyama,
Y.
Nakashima,
Y.
Kobayashi,
H.
Yukiue,
M.
Kaji,
I.
Fukai,
M.
Kiriyama,
Y.
Yamakawa,
Y.
Fujii
(2002)
Expression of the MTA1 mRNA in advanced lung cancer.
Lung cancer, 35 2
-
References
-
Haruo
Iguchi,
G.
Imura,
Y.
Toh,
Y.
Ogata
(2000)
Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer.
International journal of oncology, 16 6
-
G.
Chatta
(2003)
Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer
Urologic Oncology-seminars and Original Investigations, 21
-
M.
Mahoney,
Anisha
Simpson,
M.
Jost,
M.
Noé,
C.
Kari,
Deanna
Pepe,
Y.
Choi,
J.
Uitto,
U.
Rodeck
(2002)
Metastasis-associated protein (MTA)1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes
Oncogene, 21
-
Akihiro
Nawa,
K.
Nishimori,
Paul
Lin,
Yoshiyuki
Maki,
Kennsuke
Moue,
H.
Sawada,
Y.
Toh,
Kikkawa
Fumitaka,
G.
Nicolson
(2000)
Tumor metastasis‐associated human MTA1 gene: Its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides
Journal of Cellular Biochemistry, 79
-
D.
Gleason
(1988)
Histologic grade, clinical stage, and patient age in prostate cancer.
NCI monographs : a publication of the National Cancer Institute, 7
-
D.
Bostwick,
C.
Foster
(1999)
Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer.
Seminars in urologic oncology, 17 4
-
Y.
Toh,
S.
Pencil,
G.
Nicolson
(1994)
A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses.
The Journal of biological chemistry, 269 37
-
A.
Marzo,
V.
Marchi,
J.
Epstein,
W.
Nelson
(1999)
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.
The American journal of pathology, 155 6
-
Gleason
Df
(1988)
Histologic grade, clinical stage, and patient age in prostate cancer.
-
(2004)
American Association for Cancer cancerres.aacrjournals.org Downloaded from
-
W.
Nelson,
A.
Marzo,
T.
DeWeese,
Xiaohui
Lin,
J.
Brooks,
M.
Putzi,
Chad
Nelson,
J.
Groopman,
T.
Kensler
(2001)
Preneoplastic Prostate Lesions
Annals of the New York Academy of Sciences, 952
-
L.
Butler,
Y.
Webb,
D.
Agus,
B.
Higgins,
Thomas
Tolentino,
Martha
Kutko,
M.
LaQuaglia,
M.
Drobnjak,
C.
Cordon-Cardo,
H.
Scher,
R.
Breslow,
V.
Richon,
R.
Rifkind,
PA
Marks
(2001)
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase.
Clinical cancer research : an official journal of the American Association for Cancer Research, 7 4
-
Y.
Toh,
H.
Kuwano,
Masaki
Mori,
G.
Nicolson,
K.
Sugimachi
(1999)
Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas
British Journal of Cancer, 79
-
S.
Varambally,
S.
Dhanasekaran,
Ming
Zhou,
T.
Barrette,
Chandan
Kumar-Sinha,
M.
Sanda,
D.
Ghosh,
K.
Pienta,
R.
Sewalt,
A.
Otte,
M.
Rubin,
A.
Chinnaiyan
(2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
Nature, 419
-
M.
Rubin,
Ming
Zhou,
S.
Dhanasekaran,
S.
Varambally,
T.
Barrette,
M.
Sanda,
K.
Pienta,
D.
Ghosh,
A.
Chinnaiyan
(2002)
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
JAMA, 287 13
-
H.
Sasaki,
H.
Yukiue,
Y.
Kobayashi,
Y.
Nakashima,
Masahiro
Kaji,
I.
Fukai,
M.
Kiriyama,
Y.
Yamakawa,
Y.
Fujii
(2001)
Expression of the MTA1 mRNA in thymoma patients.
Cancer letters, 174 2
-
Y.
Toh,
S.
Pencil,
Garth
Nicolson
(1995)
Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines.
Gene, 159 1
-
the Specialized Program of Research Excellence for Prostate Cancer National Cancer Institute (NCI) Grant P50CA69568 (to
-
Association for Cancer Research Copyright © 2004 on February 23, 2013 cancerres.aacrjournals
-
W.
Xin,
D.
Rhodes,
C.
Ingold,
A.
Chinnaiyan,
M.
Rubin
(2003)
Dysregulation of the annexin family protein family is associated with prostate cancer progression.
The American journal of pathology, 162 1
-
P.
Munster,
T.
Troso-Sandoval,
N.
Rosen,
R.
Rifkind,
PA
Marks,
V.
Richon
(2001)
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.
Cancer research, 61 23
-
D.
Rhodes,
M.
Sanda,
A.
Otte,
A.
Chinnaiyan,
M.
Rubin
(2003)
Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.
Journal of the National Cancer Institute, 95 9